NeuroSense Therapeutics Ltd. Increase (Decrease) in Accounts Payable, Trade
NeuroSense Therapeutics Ltd. (NRSN) reported Increase (Decrease) in Accounts Payable, Trade of -$361.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-03-31
| Period end | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|
| 2025-12-31 | -$361.00K 20-F · filed 2026-03-31 | |
| 2025-06-30 | -$67.00K 6-K · filed 2025-08-01 | |
| 2024-12-31 | -$299.00K 20-F · filed 2026-03-31 | |
| 2024-06-30 | $24.00K 6-K · filed 2025-08-01 | |
| 2023-12-31 | $961.00K 20-F · filed 2026-03-31 | |
| 2023-06-30 | $592.00K 6-K · filed 2024-09-30 | |
| 2022-12-31 | $459.00K 20-F · filed 2025-04-07 | |
| 2021-12-31 | -$16.00K 6-K · filed 2024-06-17 |